Genetic Variants in Five Novel Loci Including CFB and CD40 Predispose to Chronic Hepatitis B

Hepatology

Volumn 62, Issue 1, 2015, Pages 118-128

  Jiang, De Ke ^a,b,c   Ma, Xiao Pin ^a   Yu, Hongjie ^d   Cao, Guangwen ^e   Ding, Dong Lin ^a   Chen, Haitao ^a,b   Huang, Hui Xing ^a   Gao, Yu Zhen ^f   Wu, Xiao Pan ^g   Long, Xi Dai ^h   Zhang, Hongxing ⁱ   Zhang, Youjie ^j,k   Gao, Yong ^j,k   Chen, Tao Yang ^l   Ren, Wei Hua ^m   Zhang, Pengyin ^a,b   Shi, Zhuqing ^a,b   Jiang, Wei ^a   Wan, Bo ^a   Saiyin, Hexige ^a   Yin, Jianhua ^e   Zhou, Yuan Feng ^h   Zhai, Yun ⁱ   Lu, Pei Xin ^l   Zhang, Hongwei ^e   Gu, Xiaoli ⁱ   Tan, Aihua ^j,k   Wang, Jin Bing ^l   Zuo, Xian Bo ^n,o   Sun, Liang Dan ^n,o   Liu, Jun O ^p   Yi, Qing ^q   Mo, Zengnan ^j,k   Zhou, Gangqiao ⁱ   Liu, Ying ^g   Sun, Jielin ^c   Shugart, Yin Yao ^r   Zheng, S Lilly ^a,c,s   Zhang, Xue Jun ^n,o   Xu, Jianfeng ^a,b,s   Yu, Long ^a,b   more..

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d ZHEJIANG UNIVERSITY   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^g INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^h YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

ⁱ BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^j FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^k GUANGXI MEDICAL UNIVERSITY   (China)

^l QIDONG LIVER CANCER INSTITUTE   (China)

^m ZHENGZHOU UNIVERSITY   (China)

ⁿ ANHUI MEDICAL UNIVERSITY   (China)

^o Ministry of National Science and Technology   (China)

^p JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^r NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^s NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CD40 LIGAND; HLA ANTIGEN; HLA C ANTIGEN; HLA DOA ANTIGEN; HLA DPA1 ANTIGEN; HLA DPA2 ANTIGEN; HLA DPB1 ANTIGEN; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DQB2 ANTIGEN; NOTCH4 RECEPTOR; UNCLASSIFIED DRUG; CD40 ANTIGEN;

ARTICLE; CHINA; CHINESE; CHRONIC HEPATITIS B; COMPLEMENT SYSTEM; CONTROLLED STUDY; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HLA SYSTEM; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION STUDY; BLOOD; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETICS; HEPATITIS B; MALE; METABOLISM; MIDDLE AGED;

ANTIGENS, CD40; COMPLEMENT FACTOR B; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEPATITIS B, CHRONIC; HLA-C ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED;

EID: 84933179399     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27794     Document Type: Article

References (43)

1. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009;373:582-592.
2. He YL, Zhao YR, Zhang SL, Lin SM. Host susceptibility to persistent hepatitis B virus infection. World J Gastroenterol 2006;12:4788-4793.
3. Lin TM, Chen CJ, Wu MM, Yang CS, Chen JS, Lin CC, et al. Hepatitis B virus markers in Chinese twins. Anticancer Res 1989;9:737-741.
4. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009;41:591-595.
5. Mbarek H, Ochi H, Urabe Y, Kumar V, Kubo M, Hosono N, et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet 2011;20:3884-3892.
6. Kim YJ, Kim HY, Lee JH, Yu SJ, Yoon JH, Lee HS, et al. A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Hum Mol Genet 2013;22:4233-4238.
7. Hu Z, Liu Y, Zhai X, Dai J, Jin G, Wang L, et al. New loci associated with chronic hepatitis B virus infection in Han Chinese. Nat Genet 2013;45:1499-1503.
8. Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 2013;45:72-75.
9. Xie J, Zhang Y, Zhang Q, Han Y, Yin J, Pu R, et al. Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma. Hepatology 2013;57:2369-2377.
10. Gao Y, He Y, Ding J, Wu K, Hu B, Liu Y, et al. An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis 2009;30:2064-2069.
11. Wang L, Wu XP, Zhang W, Zhu DH, Wang Y, Li YP, et al. Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies. PLoS One 2011;6:e17608.
12. Zhang H, Zhai Y, Hu Z, Wu C, Qian J, Jia W, et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 2010;42:755-758.
13. Long XD, Ma Y, Zhou YF, Ma AM, Fu GH. Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population. Hepatology 2010;52:1301-1309.
14. Zheng X, Shen J, Cox C, Wakefield JC, Ehm MG, Nelson MR, Weir BS. HIBAG--HLA genotype imputation with attribute bagging. Pharmacogenomics J 2014;14:192-200.
15. Blais ME, Dong T, Rowland-Jones S. HLA-C as a mediator of natural killer and T-cell activation: spectator or key player? Immunology 2011;133:1-7.
16. Gros P, Milder FJ, Janssen BJ. Complement driven by conformational changes. Nat Rev Immunol 2008;8:48-58.
17. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010;11:785-797.
18. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A 2010;107:7401-7406.
19. Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A 2010;107:7395-7400.
20. Yu Y, Bhangale TR, Fagerness J, Ripke S, Thorleifsson G, Tan PL, et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet 2011;20:3699-3709.
21. Cipriani V, Leung HT, Plagnol V, Bunce C, Khan JC, Shahid H, et al. Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3. Hum Mol Genet 2012;21:4138-4150.
22. Sobrin L, Ripke S, Yu Y, Fagerness J, Bhangale TR, Tan PL, et al. Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology 2012;119:1874-1885.
23. Naj AC, Scott WK, Courtenay MD, Cade WH, Schwartz SG, Kovach JL, et al. Genetic factors in nonsmokers with age-related macular degeneration revealed through genome-wide gene-environment interaction analysis. Ann Hum Genet 2013;77:215-231.
24. Maillard I, Adler SH, Pear WS. Notch and the immune system. Immunity 2003;19:781-791.
25. Radtke F, Fasnacht N, Macdonald HR. Notch signaling in the immune system. Immunity 2010;32:14-27.
26. Poluektov YO, Kim A, Sadegh-Nasseri S. HLA-DO and its role in MHC class II antigen presentation. Front Immunol 2013;4:260.
27. Mellins ED, Stern LJ. HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation. Curr Opin Immunol 2014;26:115-122.
28. Munroe ME. Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis. Semin Immunol 2009;21:283-288.
29. Rau SJ, Hildt E, Himmelsbach K, Thimme R, Wakita T, Blum HE, Fischer R. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway. Hepatology 2013;57:23-36.
30. Isogawa M, Chung J, Murata Y, Kakimi K, Chisari FV. CD40 activation rescues antiviral CD8(+) T cells from PD-1-mediated exhaustion. PLoS Pathog 2013;9:e1003490.
31. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol 2002;169:5188-5195.
32. Jacobson EM, Concepcion E, Oashi T, Tomer Y. A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 2005;146:2684-2691.
33. Park JH, Chang HS, Park CS, Jang AS, Park BL, Rhim TY, et al. Association analysis of CD40 polymorphisms with asthma and the level of serum total IgE. Am J Respir Crit Care Med 2007;175:775-782.
34. Skibola CF, Nieters A, Bracci PM, Curry JD, Agana L, Skibola DR, et al. A functional TNFRSF5 gene variant is associated with risk of lymphoma. Blood 2008;111:4348-4354.
35. Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP, et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008;40:1216-1223.
36. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009;41:824-828.
37. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010;42:508-514.
38. Patsopoulos NA, Esposito F, Reischl J, Lehr S, Bauer D, Heubach J, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011;70:897-912.
39. Lee YC, Kuo HC, Chang JS, Chang LY, Huang LM, Chen MR, et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet 2012;44:522-525.
40. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119-124.
41. Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H, et al. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 2012;44:517-521.
42. Shen L, Gu Y, Sun L, Yang Y, Wang F, Li Y, Bi S. Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China. J Med Virol 2012;84:445-449.
43. Liu J, Fan D. Hepatitis B in China. Lancet 2007;369:1582-1583.